Avanos Medical AVNS Interest Expense, Nonoperating
Interest Expense, Nonoperating at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's interest expense, nonoperating.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's interest expense, nonoperating?
- Avanos Medical (AVNS) reported interest expense, nonoperating of $1.5M in Q1 2026.
- How has Avanos Medical's interest expense, nonoperating changed year-over-year?
- Avanos Medical's interest expense, nonoperating decreased by 28.6% year-over-year, from $2.1M to $1.5M.
- What is the long-term trend for Avanos Medical's interest expense, nonoperating?
- Over 3 years (2022 to 2025), Avanos Medical's interest expense, nonoperating has grown at a -7.9% compound annual growth rate (CAGR), from $10M to $7.8M.
- What does interest expense, nonoperating mean?
- Represents the cost of servicing debt obligations, including interest on loans and credit facilities, excluding any capitalized interest. It serves as a measure of the company's financial leverage and the burden of its capital structure.